Your browser doesn't support javascript.
loading
Comparative study between virus neutralisation testing and other serological methods detecting anti-SARS-CoV-2 antibodies in Europe, 2021.
Mögling, Ramona; Reimerink, Johan; Stanoeva, Kamelia R; Keramarou, Maria; Guiomar, Raquel; Costa, Inês; Haveri, Anu; Holzer, Barbara; Korukluoglu, Gülay; Nguyen, Trung; Pakarna, Gatis; Pancer, Katarzyna; Trilar, Katarina Prosenc; Protic, Jelena; Stojanovic, Marijana; De Santis, Riccardo; Lista, Florigio; Vremera, Teodora; Leustean, Mihaela; Pistol, Adriana; Zelena, Hana; Reusken, Chantal; Broberg, Eeva K.
Afiliação
  • Mögling R; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands. Electronic address: ramona.moegling@rivm.nl.
  • Reimerink J; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Stanoeva KR; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Keramarou M; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Guiomar R; The National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
  • Costa I; The National Institute of Health Dr Ricardo Jorge, Lisbon, Portugal.
  • Haveri A; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.
  • Holzer B; Austrian Agency for Health and Food Safety GmbH, Vienna, Austria.
  • Korukluoglu G; Public Health General Directorate of Turkey, Ankara, Turkey.
  • Nguyen T; Laboratoire National de Santé, Dudelange, Luxembourg.
  • Pakarna G; Riga East Clinical University Hospital, Riga, Latvia.
  • Pancer K; National Institute of Public Health NIH-NRI, Warsaw, Poland.
  • Trilar KP; National Laboratory for Health, Environment and Food, Slovenia.
  • Protic J; Institute of Virology, Vaccines, and Sera - Torlak, Belgrade, Serbia.
  • Stojanovic M; Institute of Virology, Vaccines, and Sera - Torlak, Belgrade, Serbia.
  • De Santis R; Scientific Department, Army Medical Center, Rome, Italy.
  • Lista F; Scientific Department, Army Medical Center, Rome, Italy.
  • Vremera T; National Institute for Public Health, Bucharest, Romania.
  • Leustean M; National Institute for Public Health, Bucharest, Romania.
  • Pistol A; National Institute for Public Health, Bucharest, Romania.
  • Zelena H; Public Health Institute Ostrava, Ostrava, Czech Republic.
  • Reusken C; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.
  • Broberg EK; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
J Virol Methods ; 322: 114825, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37778539
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Virol Methods Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Virol Methods Ano de publicação: 2023 Tipo de documento: Article